Gucy2d Related Dominant Retinopathy Cn305591
A hereditary form of retinal disease causing progressive vision loss. Can run in families. Low vision aids and monitoring for complications are main approaches.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Visual acuity decline
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Photophobia
(ophthalmologic)Central scotoma
(ophthalmologic)Color vision deficiency
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Annual Retinal Imaging and Function Testing
Regular OCT imaging, electroretinography, and visual field testing to document disease course and evaluate potential therapeutic interventions.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Low Vision Aids and Technology Support
Provision of electronic magnification devices, screen readers, and adaptive software to support daily activities and employment.
Additional treatment options
Environmental Modifications
Home and workplace modifications including enhanced lighting, contrast enhancement, and organizational strategies to optimize functional vision.
lifestyleDietary Assessment and Supplementation
Evaluation of nutritional status with consideration of vitamin A, lutein, and omega-3 supplementation based on current evidence.
complementarySupport Group and Counseling Services
Connection with patient advocacy groups and mental health support to address vision loss-related emotional adjustment and family dynamics.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Gucy2d Related Dominant Retinopathy Cn305591?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Koch KW, Dell'Orco D. Protein Interactions in Retinal Guanylate Cyclase Signaling and Disease Mechanisms. Prog Retin Eye Res. 2020.
American Academy of Ophthalmology. Recommendations for Genetic Testing in Inherited Retinal Diseases. Ophthalmology. 2021.
Michaelides M, Gaillard MC, Escher P, Tiab L, Bedell M, Borruat FX, et al. Clinical and Genetic Features of GUCY2D-Associated Cone Dystrophy. Invest Ophthalmol Vis Sci. 2018.
Thompson DA, Khan NW, Othman MI, Chang S, Li Y, Swaroop A. Phenotypic and Molecular Characterization of GUCY2D-Related Inherited Retinal Disorders. Retina. 2022.
Medication Comparisons
Compare medications used to treat Gucy2d Related Dominant Retinopathy Cn305591. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy